Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RVL Pharmaceuticals (RVLP)
OTHER OTC:RVLP
Holding RVLP?
Track your performance easily
RVLP Stock Chart & Stats
Day’s Range$0.03 - $0.04
52-Week Range― - ―
Previous Close$0.04
Volume63.96M
Average Volume (3M)N/A
Market Cap
$512.47K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 15, 2023EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2.50Price Target Upside8765.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
RVL Pharmaceuticals News
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
19.05% Other Institutional Investors
80.95% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RVLP FAQ
What was RVL Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is RVL Pharmaceuticals’s market cap?
Currently, no data Available
When is RVL Pharmaceuticals’s upcoming earnings report date?
RVL Pharmaceuticals’s upcoming earnings report date is Nov 15, 2023 which is 376 days ago.
How were RVL Pharmaceuticals’s earnings last quarter?
RVL Pharmaceuticals released its earnings results on Aug 14, 2023. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.112 by -$0.128.
Is RVL Pharmaceuticals overvalued?
According to Wall Street analysts RVL Pharmaceuticals’s price is currently Undervalued.
Does RVL Pharmaceuticals pay dividends?
RVL Pharmaceuticals does not currently pay dividends.
What is RVL Pharmaceuticals’s EPS estimate?
RVL Pharmaceuticals’s EPS estimate is -$0.08.
How many shares outstanding does RVL Pharmaceuticals have?
Currently, no data Available
What happened to RVL Pharmaceuticals’s price movement after its last earnings report?
RVL Pharmaceuticals reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.112. Following the earnings report the stock price went down -15.217%.
Which hedge fund is a major shareholder of RVL Pharmaceuticals?
Currently, no hedge funds are holding shares in RVLP
---
RVL Pharmaceuticals Stock Smart Score
Company Description
RVL Pharmaceuticals
Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company, which engages in the development and commercialization of specialty products for neurology and women's health. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
---
RVLP Stock 12 Month Forecast
Average Price Target
$2.50
▲(8765.25% Upside)
Technical Analysis
Teva Pharmaceutical
―
Perrigo Company
―
Revance Therapeutics
―
Onconova Therapeutics
―
Best Analysts Covering RVLP
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-21.64%
reiterated a buy rating a year ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -21.64% per trade.
---